BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22507779)

  • 1. Monoclonal antibodies in adult acute lymphoblastic leukemia.
    Kantarjian H
    Hematology; 2012 Apr; 17 Suppl 1():S52-4. PubMed ID: 22507779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies and immune therapies for adult precursor B-acute lymphoblastic leukemia.
    Sikaria S; Aldoss I; Akhtari M
    Immunol Lett; 2016 Apr; 172():113-23. PubMed ID: 26921100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy with monoclonal antibodies in acute lymphoblastic leukemia.
    Hoelzer D
    Curr Opin Oncol; 2013 Nov; 25(6):701-6. PubMed ID: 24097105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD22/CD20 Bispecific antibody with enhanced trogocytosis for treatment of Lupus.
    Rossi EA; Chang CH; Goldenberg DM
    PLoS One; 2014; 9(5):e98315. PubMed ID: 24841238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibody therapy with rituximab for acute lymphoblastic leukemia.
    Thomas DA; O'Brien S; Kantarjian HM
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):949-71, v. PubMed ID: 19825447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia.
    Jabbour E; Pui CH; Kantarjian H
    JAMA Oncol; 2018 Oct; 4(10):1413-1420. PubMed ID: 29931220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.
    Farhadfar N; Litzow MR
    Leuk Res; 2016 Oct; 49():13-21. PubMed ID: 27521873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Countering immunotoxin immunogenicity.
    Flavell DJ
    Br J Cancer; 2016 May; 114(11):1177-9. PubMed ID: 27219287
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel targets for treatment of adult acute lymphocytic leukemia.
    Kasner MT
    Curr Hematol Malig Rep; 2010 Oct; 5(4):207-12. PubMed ID: 20680526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia.
    Jain N; O'Brien S; Thomas D; Kantarjian H
    Front Biosci (Elite Ed); 2014 Jan; 6(1):40-5. PubMed ID: 24389139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoimmunotherapy in acute lymphoblastic leukemia.
    Hoelzer D; Gökbuget N
    Blood Rev; 2012 Jan; 26(1):25-32. PubMed ID: 21958552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody-based therapies in the treatment of acute lymphoblastic leukemia.
    Litzow MR
    Am Soc Clin Oncol Educ Book; 2013; ():294-9. PubMed ID: 23714527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies in acute lymphoblastic leukemia.
    Jabbour E; O'Brien S; Ravandi F; Kantarjian H
    Blood; 2015 Jun; 125(26):4010-6. PubMed ID: 25999456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibody therapy targeting surface antigens of leukemic cells].
    Meng FY; Fu YB
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(7):441-3. PubMed ID: 15854546
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP).
    Gómez-Almaguer D
    Hematology; 2012 Apr; 17 Suppl 1():S25-7. PubMed ID: 22507772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inotuzumab: the most active single agent in acute lymphoblastic leukemia?
    Thomas DA
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):251-4. PubMed ID: 22706486
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects.
    Gökbuget N; Hoelzer D
    Ann Hematol; 2004 Apr; 83(4):201-5. PubMed ID: 14648023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple signaling pathways induced by hexavalent, monospecific, anti-CD20 and hexavalent, bispecific, anti-CD20/CD22 humanized antibodies correlate with enhanced toxicity to B-cell lymphomas and leukemias.
    Gupta P; Goldenberg DM; Rossi EA; Chang CH
    Blood; 2010 Oct; 116(17):3258-67. PubMed ID: 20628151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia.
    Kantarjian H; Thomas D; Wayne AS; O'Brien S
    J Clin Oncol; 2012 Nov; 30(31):3876-83. PubMed ID: 22891271
    [No Abstract]   [Full Text] [Related]  

  • 20. Epratuzumab and Blinatumomab as Therapeutic Antibodies for Treatment of Pediatric Acute Lymphoblastic Leukemia: Current Status and Future Perspectives.
    Franca R; Favretto D; Granzotto M; Decorti G; Rabusin M; Stocco G
    Curr Med Chem; 2017; 24(11):1050-1065. PubMed ID: 28088906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.